DK2403
DK2403 (compound 25) is a MAP2K7 inhibitor (IC50= 0.01 μM) . DK2403 can effectively inhibit MAP2K7 without significantly disrupting the larger kinase group and can be used to study childhood T-cell acute lymphoblastic leukemia[1].
Product Specifications
CAS Number
2902651-64-1
UNSPSC
12352005
Target
P38 MAPK
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
98.24
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(CCl)NC1=CC(OC2=NC=NC(NCC3=CC=CC=C3)=C2)=CC=C1
Molecular Formula
C19H17ClN4O2
Molecular Weight
368.82
References & Citations
[1]Kim DR, et al. Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors. ACS Med Chem Lett. 2023 Apr 17;14 (5) :606-613.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0978605 3x 1.0 µg
HNRNPUL1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details LS005606 100 µg
MEK3 (MAP2K3) (NM_145109) Human Over-expression Lysate
Sign In for Pricing
View Details 
orb2909744-01 20 µg
Recombinant Escherichia coli Inner membrane transport permease ybhR (ybhR)
Sign In for Pricing
View Details 
orb2909744-02 100 µg
Recombinant Escherichia coli Inner membrane transport permease ybhR (ybhR)
Sign In for Pricing
View Details TA506032 100 µL
MEK1 (MAP2K1) Mouse Monoclonal Antibody [Clone ID: OTI7F3]
Sign In for Pricing
View Details